Chapter 357 |
2022 -- S 3029 Enacted 06/29/2022 |
A N A C T |
RELATING TO HEALTH AND SAFETY -- RHODE ISLAND PROGRAM TO ADDRESS ALZHEIMER'S DISEASE |
Introduced By: Senator Cynthia Armour Coyne |
Date Introduced: June 17, 2022 |
It is enacted by the General Assembly as follows: |
SECTION 1. Sections 23-1.7-2, 23-1.7-4, 23-1.7-5 and 23-1.7-6 of the General Laws in |
Chapter 23-1.7 entitled "Rhode Island Program to Address Alzheimer's Disease" are hereby |
amended to read as follows: |
23-1.7-2. Creation of advisory council. |
(a) There is hereby established a council to be called the "Advisory Council advisory |
council on Alzheimer's Disease disease Research and Treatment and related disorders." The |
advisory council shall consist of thirteen (13) nineteen (19) members to be composed as follows: |
the lieutenant governor, or designee; the director of the department of health, or designee; the |
director of the office of healthy aging, or designee; the chairperson of the long-term care |
coordinating council; three (3) members appointed by the lieutenant governor, one of whom shall |
be appointed solely by the lieutenant governor without reference to any list; one of whom shall be |
appointed and selected from a list of five (5) names of individuals submitted by the speaker of the |
house, with two (2) individuals having experience as caregivers of persons with Alzheimer's disease |
and related disorders and reflecting diverse backgrounds, including diversity in race and ethnicity; |
one of whom shall be appointed and selected from a list of five (5) names of individuals submitted |
by the president of the senate, with two (2) individuals having experience as caregivers of persons |
with Alzheimer's disease and related disorders and reflecting diverse backgrounds, including race |
and ethnicity; one member appointed by the speaker of the house; one member appointed by the |
president of the senate; and seven (7) ten (10) members appointed by the governor. The members |
appointed by the governor shall include one member who is an Alzheimer's disease patient |
advocate; one member who is an Alzheimer's disease caregiver; one member who is a healthcare |
provider; one member who is a researcher with Alzheimer's-related expertise in basic, translational, |
clinical, or drug-development science; one member who is a representative from an Alzheimer's |
disease organization that funds research and has demonstrated experience in care and patient |
services; one member from an Alzheimer's advocacy organization that provides services to families |
and professionals, including information and referrals, support groups, care consultation, |
education, and safety services; one member who is a representative from an organization focused |
on Alzheimer's workforce development; one member who is a representative from the long-term- |
care industry; one member who will represent the adult primary care community; and one member |
who is a representative of a healthcare insurer. Advisory council members shall select their own |
chairperson. Seven (7) Ten (10) members shall constitute a quorum. |
(b) The member appointed by the speaker of the house,, the member appointed by the |
president of the senate, and three (3) members appointed by the governor shall be initially appointed |
for a term to expire July 1, 2020, and four (4) members to be appointed by the governor shall be |
initially appointed for a term to expire July 1, 2021. After the initial term, the appointed members |
shall serve two-year (2) terms, until their successor is appointed. |
23-1.7-4. Assessment protocol. |
(a) The director of the department of health shall establish and publish on their the |
department’s website an Alzheimer's disease assessment protocol specifically focused on |
recognizing the signs and symptoms of cognitive impairments, including, but not limited to, |
Alzheimer's disease and appropriate resource information for effective medical screening, |
investigation, and service planning. |
(b) The director of the department of health shall make available upon request a copy of |
the assessment protocol to protective-services caseworkers, healthcare professionals, and members |
of the public. |
(c) Protective-services caseworkers assigned to or employed by the office of healthy aging |
shall be familiar with the information contained in the assessment protocol. |
23-1.7-5. Medical professional training. |
(a) All physicians licensed pursuant to chapter 37 of title 5, and nurses licensed pursuant |
to chapter 34 of title 5, shall, no later than October 1, 2021 2023, complete a one-time course of |
training consisting of a minimum of one hour of instruction on the diagnosis, treatment, and care |
of patients with cognitive impairments including, but not limited to, Alzheimer's disease and |
dementia related disorders. |
(b) The department of health shall promulgate rules to implement the training requirement |
of subsection (a). |
23-1.7-6. Healthcare facility plan. |
(a) Every healthcare facility as defined in § 23-17-2 shall, not later than October 1, 2021 |
2023, complete and implement an operational plan for the recognition and management of patients |
with Alzheimer's disease or dementia and related disorders. |
(b) The department of health shall promulgate rules and regulations to implement the |
operational plan requirements of subsection (a). |
(c) The director of the department of health, in consultation with the advisory council on |
Alzheimer's disease and related disorders, shall determine which health care healthcare facilities |
defined in § 23-17-2 will be subject to the requirements of subsection (a) of this section. |
SECTION 2. This act shall take effect upon passage. |
======== |
LC006150 |
======== |